FDA questions Lilly, Amgen cancer drug trials (Reuters)

[riky]

FDA questions Lilly, Amgen cancer drug trials
    (Reuters)

 


Reuters - U.S. health regulators are questioning whether clinical trials proposed by ImClone Systems and Amgen Inc will be adequate to show that patients with a certain type of gene are more likely to be helped by two cancer drugs, according to documents released on Friday.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20081212/hl_nm/us_cancer_fda